Andrea Necchi (@andreanecchi) 's Twitter Profile
Andrea Necchi

@andreanecchi

Associate Professor @MyUniSR - Director of Genitourinary Medical Oncology @SanRaffaeleMI - Vice President @GTumors - Associate Editor @JCO_ASCO

ID: 547064288

linkhttp://www.andreanecchi.com calendar_today06-04-2012 19:53:04

2,2K Tweet

3,3K Followers

947 Following

Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo

Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease brnw.ch/21wLDHK

UroToday.com (@urotoday) 's Twitter Profile Photo

Optimizing next-gen sequencing in #Urothelial cancer - #Expert #Consensus recommendations! Andrea Necchi and Ashish M. Kamat, MD, MBBS underscore the need for careful tissue mgmt, recommending NGS especially when clinical trial opportunities are present. #WatchNow > bit.ly/46HB8nJ

Optimizing next-gen sequencing in #Urothelial cancer - #Expert #Consensus recommendations!
<a href="/AndreaNecchi/">Andrea Necchi</a> and <a href="/UroDocAsh/">Ashish M. Kamat, MD, MBBS</a> underscore the need for careful tissue mgmt, recommending NGS especially when clinical trial opportunities are present.
#WatchNow &gt; bit.ly/46HB8nJ
Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo

Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer brnw.ch/21wLQOA

Jonathan Friedberg (@drjfriedberg) 's Twitter Profile Photo

Cannabis for Refractory Chemotherapy-Induced Nausea and Vomiting: the applicability and generalizability of the evidence is limited by changes in antiemetic guidelines and availability of THC:CBD. Thoughtful Journal of Clinical Oncology editorial by Dr Zimmermann ascopubs.org/doi/full/10.12…

Journal of Clinical Oncology (@jco_asco) 's Twitter Profile Photo

📢Calling all oncology researchers! We’re accepting submissions for JCO Oncology Advances. Share impactful cancer research with a global community and contribute to advancing clinical oncology. Submit your work ➡️ brnw.ch/21wM6Ts #JCO #OncologyResearch #OpenAccess

Andrea Necchi (@andreanecchi) 's Twitter Profile Photo

MRI should be a routine for daily management of MIBC. cCR definition and modern bladder-sparing strategies will rely on it. Congratulations a step forward to this direction

Liang Cheng, MD (@liangchengmd) 's Twitter Profile Photo

What’s the difference between urachal and nonurachal adenocarcinoma the bladder? You may take a look of this most recent paper published this month in JCO Precision Oncology JCO Precision Oncology This important study, led by Dr. Andea Necchi Andrea Necchi, represents the largest cohort

What’s the difference between urachal and nonurachal adenocarcinoma the bladder? You may take a look of this most recent paper published this month in JCO Precision Oncology <a href="/JCOPO_ASCO/">JCO Precision Oncology</a> 

This important study, led by Dr. Andea Necchi <a href="/AndreaNecchi/">Andrea Necchi</a>, represents the largest cohort
ecancer (@ecancer) 's Twitter Profile Photo

Neoadjuvant sacituzumab govitecan shows promising activity in muscle-invasive urothelial bladder cancer. Watch Dr Antonio Cigliola discuss the SURE-01/02 study👉 bit.ly/3AZkofG Ospedale San Raffaele #ASCO2024

Jonathan Friedberg (@drjfriedberg) 's Twitter Profile Photo

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: use of large language models required 9 seconds/chart versus 15 minutes for clinician adjudication and demonstrated higher sensitivity with similar specificity. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…